Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Stereotactic surgery Stories

2012-10-29 11:25:24

SHREWSBURY, England, October 29, 2012 /PRNewswire/ -- Continued Collaboration with Leading Clinical and Research University Hospital Provides Leading-Edge Research in Clinical Radiation Oncology Workflow Oncology Systems Limited UK (OSL), innovators in radiation therapy solutions, announced today the signing of a multi-year research and collaboration agreement with The UHB Radiotherapy Department and the Medical Physics Department. UHB researchers play a vital role in...

2012-10-29 07:25:51

BOSTON, Oct. 29, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) yesterday unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining...

2012-10-28 19:20:15

BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) today unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining state-of-the-art...

2012-10-28 11:20:17

SUNNYVALE, Calif. and BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO 2012 -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today launched its new TomoTherapy® H(TM) Series, featuring the TomoHDA(TM) System, with faster planning, faster delivery and increased quality. The TomoHDA System was unveiled at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting in Boston. Key features of the TomoHDA System include: Accuray's new TomoEDGE(TM)...

2012-10-22 11:25:38

ATLANTA, Oct. 22, 2012 /PRNewswire/ -- In the last six months, cancer clinics in 21 countries have accepted delivery of Elekta's Agility(TM)*, an innovative, ground-breaking 160-leaf multi-leaf collimator (MLC) that utilizes industry-leading technology to provide faster, more accurate, and more versatile radiation therapy for individuals with cancer. Agility was recently introduced at Radboud University Nijmegen Medical Center (Nijmegen, Netherlands), where a 48-year-old woman, was...

2012-10-18 07:26:52

SUNNYVALE, Calif., Oct. 18, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, will announce significant product news at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting taking place at the Boston Convention Center. Accuray will unveil two advanced technology platforms designed to deliver unparalleled, precise and personalized treatment to the full range of cancer patients. There will be many opportunities to learn about...

2012-10-15 07:28:09

NIJMEGEN, Netherlands, Oct. 15, 2012 /PRNewswire/ - The first of three newly acquired Elekta Synergy® treatment systems equipped with Agility(TM)* 160-leaf multi-leaf collimator (MLC) is now up and running clinically at Radboud University Nijmegen Medical Center - making the clinic the first in the Netherlands to use Agility. The first patient, a 48-year-old woman, was treated on September 10 and clinicians have treated 70 additional patients since then, encompassing a wide...

2012-10-12 07:23:09

SUNNYVALE, Calif., Oct. 12, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that Euan S. Thomson has resigned as President and Chief Executive Officer and Director of the Board. Accuray's Board has appointed Joshua H. Levine as his successor as President and CEO and Director of the Board, effective immediately. Thomson is anticipated to continue in a consulting role with the Company. Thomson joined Accuray in March 2002 as...

2012-10-02 02:30:07

PALO ALTO, Calif., Oct. 2, 2012 /PRNewswire/ -- The Journal of Thoracic and Cardiovascular Surgery has published an article summarizing the goals of an ongoing phase III study comparing radiosurgery with surgery for the treatment of early-stage, high-risk, operable non-small cell lung cancer. Appearing in the September 2012 issue, the article by the study chair and co-chair explains why this randomized study "is necessary and timely."(1) Stereotactic body radiotherapy (SBRT)--a radiosurgical...

2012-09-27 02:27:15

GLASGOW, Scotland, Sept. 27, 2012 /PRNewswire/ -- Clinicians at one of the UK's largest radiotherapy departments have commenced brain radiosurgery treatments that enable patients to spend less time on the treatment table while aiding precision by minimizing the chance of movement during treatment. Doctors at the Beatson West of Scotland Cancer Centre in Glasgow have begun delivering the pioneering treatments using a TrueBeam(TM) STx linear accelerator from Varian Medical Systems (NYSE: VAR)....